Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

BWAY
Brainsway Ltd.
stock NASDAQ ADR

Market Open
Aug 19, 2025 12:19:01 PM EDT
14.57USD-1.886%(-0.28)58,691
0.00Bid   0.00Ask   0.00Spread
Pre-market
Aug 19, 2025 9:22:30 AM EDT
14.79USD-0.403%(-0.06)1,223
After-hours
Aug 18, 2025 4:10:30 PM EDT
15.34USD+3.369%(+0.50)0
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 31, 2022
07:35AM EST  BrainsWay Announces Final Local Coverage Determination Issued By Regional Medicare Administrative Contractor Palmetto GBA Providing Coverage Of Deep TMS For The Treatment Of OCD   Benzinga
07:30AM EST  BrainsWay Ltd. (NASDAQ & TASE: BWAY) (BrainsWay or the Company), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that a final Local Coverage Determination (LCD) has been published providing coverage applicable to the BrainsWay Deep TMS system for the treatment of obsessive-compulsive disorder (OCD).   GlobeNewswire Inc
Jan 26, 2022
08:00AM EST  BrainsWay Ltd. (NASDAQ & TASE: BWAY) (BrainsWay or the Company), a global leader in the advanced noninvasive treatment of brain disorders, today announced the addition of Professor Markus Heilig, M.D., Ph.D., to BrainsWays scientific advisory board.   GlobeNewswire Inc
Jan 12, 2022
08:00AM EST  BrainsWay Announces Multiple Publications of New Real-World OCD   GlobeNewswire Inc
Dec 9, 2021
09:46PM EST  BrainsWay Announces Publication Of Deep TMS Trial Results For Reduction Of Heavy Drinking In Alcohol-Dependent Subjects   Benzinga
07:30AM EST  Randomized, Placebo-Controlled, Double-Blind Pilot Study Evaluated Deep TMS Treatment in Reducing Alcohol Consumption and Craving for Adults with Alcohol Use Disorder   GlobeNewswire Inc
Nov 30, 2021
08:00AM EST  BrainsWay Ltd. (NASDAQ & TASE: BWAY) (BrainsWay or the Company), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that Christopher von Jako, Ph.D., President and Chief Executive Officer, will present and participate in one-on-one investor meetings at the Sidoti December Micro-Cap Investor Conference.   GlobeNewswire Inc
Nov 29, 2021
06:25AM EST  HC Wainwright & Co. Maintains Buy on BrainsWay, Raises Price Target to $15   Benzinga
Nov 17, 2021
07:57AM EST  BrainsWay Q3 Loss Per Share $0.05 Vs Loss $0.04 Last Year   RTTNews
07:39AM EST  Brainsway Q3 EPS $(0.05) Down From $(0.04) YoY, Sales $8.10M Beat $6.57M Estimate   Benzinga
07:30AM EST  BrainsWay Reports Third Quarter 2021 Financial Results and   GlobeNewswire Inc
03:59AM EST  Earnings Scheduled For November 17, 2021   Benzinga
Nov 3, 2021
08:00AM EDT  BrainsWay to Report Third Quarter 2021 Financial Results on   GlobeNewswire Inc
Oct 12, 2021
09:00AM EDT  BrainsWay Ltd. (NASDAQ & TASE: BWAY) (BrainsWay" or the Company), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the addition of Dr. Zafiris Jeff Daskalakis to BrainsWays scientific advisory board (SAB).   GlobeNewswire Inc
Sep 30, 2021
08:05AM EDT  BrainsWay Highlights Data Published In World Psychiatry On Deep Transcranial Magnetic Stimulation For Smoking Addiction   Benzinga
08:00AM EDT  Evidence Supports Use of Deep TMS as a Safe and Effective Treatment for Smoking Addiction   GlobeNewswire Inc
Sep 10, 2021
09:13AM EDT  BrainsWay Wins $184K Contract From Department Of Veterans Affairs For 'BrainsWay TMS Device'   Benzinga
Sep 9, 2021
08:00AM EDT  BrainsWay to Participate in Two Upcoming Investor Conferences   GlobeNewswire Inc
Aug 30, 2021
08:00AM EDT  BrainsWay to Present at the H.C. Wainwright 23rd Annual Global   GlobeNewswire Inc
Aug 18, 2021
12:09PM EDT  Mid-Day Market Update: Alcon Rises Following Q2 Results; NexPoint Real Estate Finance Shares Slide   Benzinga
08:41AM EDT  Benzinga Pro's Top 5 Stocks To Watch For Wednesday, Aug. 18, 2021: LOW, TRKA, AHT, VICI, BWAY   Benzinga
08:20AM EDT  FDA OKs Expanded Indication For BrainsWay Deep TMS System   RTTNews
07:44AM EDT  FDA Clears BrainsWay Deep TMS System For Decreasing Anxiety Symptoms In Depressed Patients; Stock Up   RTTNews
07:32AM EDT  FDA Clears BrainsWay Deep TMS System For Decreasing Anxiety Symptoms In Depression Patients   Benzinga
07:30AM EDT  FDA Clears BrainsWay Deep TMS System for   GlobeNewswire Inc
Aug 17, 2021
07:30AM EDT  BrainsWay Ltd. (NASDAQ & TASE: BWAY) (BrainsWay or the Company), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it will host a key opinion leader (KOL) webinar on its Deep TMS therapy for treating mental health disorders on Tuesday, August 31, 2021, at 11am Eastern Time.   GlobeNewswire Inc
Aug 12, 2021
06:34AM EDT  HC Wainwright & Co. Maintains Buy on BrainsWay, Lowers Price Target to $14   Benzinga
Aug 11, 2021
09:06AM EDT  Earnings Scheduled For August 11, 2021   Benzinga
08:10AM EDT  Brainsway Q2 EPS $(0.06) Down From $(0.03) YoY, Sales $7.00M Beat $6.19M Estimate   Benzinga
08:00AM EDT  BrainsWay Reports Second Quarter 2021 Financial Results and   GlobeNewswire Inc
04:27AM EDT  Earnings Scheduled For August 11, 2021   Benzinga
Jul 28, 2021
08:00AM EDT  BrainsWay to Report Second Quarter 2021 Financial Results on   GlobeNewswire Inc
Jul 19, 2021
10:03AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For July 19, 2021   Benzinga
06:46AM EDT  HC Wainwright & Co. Initiates Coverage On BrainsWay with Buy Rating, Announces Price Target of $17   Benzinga
Jul 6, 2021
08:00AM EDT  BrainsWay to Present at the Ladenburg Thalmann 2021 Healthcare   GlobeNewswire Inc
Jun 8, 2021
08:00AM EDT  BrainsWay to Present at the Raymond James Human Health Innovation   GlobeNewswire Inc
Jun 7, 2021
08:01AM EDT  BrainsWay Ltd. (NASDAQ & TASE: BWAY) (BrainsWay or the Company), a global leader in advanced noninvasive neurostimulation treatments of mental health disorders, today announced the Company will participate in the upcoming global medical conferences:   GlobeNewswire Inc
Jun 2, 2021
08:04AM EDT  BrainsWay Announces OCD Coverage Policy By Blue Cross Blue Shield Licensee HCSC   Benzinga
08:00AM EDT  BrainsWay Announces Positive OCD Coverage Policy by Blue Cross   GlobeNewswire Inc
Jun 1, 2021
08:00AM EDT  BrainsWay Ltd. (NASDAQ & TASE: BWAY) (BrainsWay or the Company), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that the first draft Local Coverage Determination (LCD) has been published proposing coverageapplicable to the BrainsWay Deep TMS system for the treatment of obsessive-compulsive disorder (OCD).   GlobeNewswire Inc
May 24, 2021
08:00AM EDT  BrainsWay Announces First of its Kind Positive Coverage Policy by   GlobeNewswire Inc
May 20, 2021
08:04AM EDT  Brainsway Q1 EPS $(0.11) Misses $(0.06) Estimate, Sales $6.12M Beat $5.84M Estimate   Benzinga
08:00AM EDT  BrainsWay Reports First Quarter 2021 Financial Results and   GlobeNewswire Inc
04:08AM EDT  Earnings Scheduled For May 20, 2021   Benzinga
May 19, 2021
08:00AM EDT  BrainsWay to Present at the Oppenheimer MedTech, Tools &   GlobeNewswire Inc
May 13, 2021
01:47PM EDT  Brainsway has received Health Canada approval for the Brainsway Deep TMS System for the treatment of Obsessive Compulsive Disorder   Benzinga
May 6, 2021
04:01PM EDT  BrainsWay to Report First Quarter 2021 Financial Results on May   GlobeNewswire Inc
May 5, 2021
08:32AM EDT  BrainsWay Names R. Scott Areglado As Senior Vice President, CFO   Benzinga
08:00AM EDT  BrainsWay Ltd. (NASDAQ & TASE: BWAY) (BrainsWay or the Company), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the appointment of R. Scott Areglado as Senior Vice President and Chief Financial Officer effective today.   GlobeNewswire Inc
May 4, 2021
09:02AM EDT  BrainsWay Ltd. (NASDAQ & TASE: BWAY) (BrainsWay or the Company), a global leader in the advanced noninvasive treatment of brain disorders, today announced the launch of its nationwide Sweepstakes, in conjunction with Mental Health Awareness Month. Participants can enter throughout the month of May for a chance to be one of 20 winners to receive a curated self-care package.   GlobeNewswire Inc
May 3, 2021
08:00AM EDT  BrainsWay Ltd. (NASDAQ & TASE: BWAY) (BrainsWay or the Company), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that the Company will ring the NASDAQ closing bell on Wednesday, May 5, 2021, to highlight May as Mental Health Awareness Month.   GlobeNewswire Inc
Apr 29, 2021
09:12AM EDT  BrainsWay Highlights Launch Of Noninvasive Treatment For Smoking Addiction To US Providers   Benzinga
09:03AM EDT  BrainsWay Announces Launch of Noninvasive Treatment for Smoking   GlobeNewswire Inc
Apr 26, 2021
10:25AM EDT  BrainsWay Stock Is Trading Higher After FDA OK's Three-Minute Theta Burst Treatment Protocol For Major Depressive Disorder   Benzinga
07:30AM EDT  BrainsWay Receives FDA Clearance for Three-Minute Theta Burst   GlobeNewswire Inc
05:36AM EDT  Brainsway on Friday Received FDA 510K Notice for Transcranial Magnetic Stimulator   Benzinga
Apr 20, 2021
10:04AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For April 20, 2021   Benzinga
09:18AM EDT  Northland Capital Markets Initiates Coverage On Brainsway with Outperform Rating, Announces Price Target of $15   Benzinga
Apr 14, 2021
09:10AM EDT  BrainsWay Says 10,000 Patients Have Been Treated With Deep Transcranial Magnetic Stimulation   Benzinga
09:03AM EDT  BrainsWay Ltd. (NASDAQ & TASE: BWAY) (BrainsWay or the Company), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, announced today that 100,000 patients have been treated globally with Deep transcranial magnetic stimulation (Deep TMS).   GlobeNewswire Inc
Mar 26, 2021
07:16AM EDT  Oppenheimer Maintains Outperform on Brainsway, Raises Price Target to $15   Benzinga
Mar 24, 2021
04:08PM EDT  Brainsway Q4 EPS $(0.02) Up From $(0.10) YoY, Sales $7.10M Beat $5.68M Estimate   Benzinga
04:06PM EDT  BrainsWay Ltd. (NASDAQ & TASE: BWAY) (BrainsWay or the Company), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today reported fourth quarter and full year 2020 financial results and provided an operational update.   GlobeNewswire Inc
04:29AM EDT  Earnings Scheduled For March 24, 2021   Benzinga
Mar 11, 2021
07:00AM EST  BrainsWay to Report Fourth Quarter and Full Year 2020 Financial   GlobeNewswire Inc
Mar 8, 2021
08:46AM EST  BrainsWay to Present at the Oppenheimer 31st Annual Healthcare   GlobeNewswire Inc
Mar 1, 2021
07:00AM EST  BrainsWay Ltd. Announces Closing of $45.2 Million Underwritten   GlobeNewswire Inc
Feb 23, 2021
10:25AM EST  Shares of Brainsway Ltd. (BWAY) are currently slipping nearly 15% after the medical device maker announced the pricing of its American Depositary Shares offering.   RTTNews
08:47AM EST  Brainsway Shares To Resume Trade At 9:15 a.m. EST   Benzinga
08:40AM EST  BrainsWay Prices 4.622M ADS Offering At $8.50/Share   Benzinga
08:30AM EST  BrainsWay Ltd. Announces Pricing of $39,287,000 Underwritten   GlobeNewswire Inc
Feb 22, 2021
04:03PM EST  BrainsWAy Reports Offering Of Common Stock, No Size Disclosed   Benzinga
04:02PM EST  BrainsWay Ltd. Announces Proposed Public Offering of American   GlobeNewswire Inc
04:01PM EST  Brainsway Shares Halted News Pending   Benzinga
Feb 17, 2021
07:43AM EST  Raymond James Maintains Outperform on Brainsway, Raises Price Target to $12   Benzinga
Feb 16, 2021
07:30AM EST  BrainsWay Ltd. (NASDAQ & TASE: BWAY) (BrainsWay or the Company), a global leader in the advanced non-invasive treatment of brain disorders, today announced the addition of Fran Hackett as Vice President of North American Sales effective February 16, 2021.   GlobeNewswire Inc
07:16AM EST  BrainsWay Sees Prelim. Q4 Sales $6.8M-$7.1M vs $5.68M Est., FY20 Sales $21.8M-$22.1M vs $21.44M Est.   Benzinga
07:00AM EST  BrainsWay Ltd. (NASDAQ & TASE: BWAY) (BrainsWay or the Company), a global leader in the advanced noninvasive treatment of brain disorders, today announced certain preliminary unaudited Fourth Quarter Financial Results.   GlobeNewswire Inc
Jan 25, 2021
08:07AM EST  BrainsWay Signs Exclusive Distribution Agreement With Gaelan Medical Trade LLC Under Which BrainsWay Will Supply Its Deep Transcranial Magnetic Stimulation System To Be Marketed And Sold Throughout UAE   Benzinga
08:00AM EST  BrainsWay Signs Exclusive Distribution Agreement with Gaelan   GlobeNewswire Inc
Nov 18, 2020
07:15AM EST  Brainsway Q3 EPS $(0.04) Up From $(0.12) YoY, Sales $6.00M Beat $5.45M Estimate   Benzinga
07:00AM EST  BrainsWay Ltd. (NASDAQ & TASE: BWAY) (BrainsWay or the Company), a global leader in the advanced non-invasive treatment of brain disorders, today reported financial results for the quarter ended September 30, 2020, and will provide an operational update.   GlobeNewswire Inc
Nov 17, 2020
07:00AM EST  BrainsWay Ltd. (NASDAQ & TASE: BWAY) (BrainsWay or the Company), a global leader in the advanced, non-invasive treatment of brain disorders, today announced that it will host a key opinion leader (KOL) call on Deep Transcranial Magnetic Stimulation (Deep TMS) for treating psychiatric disorders on Monday, November 23, 2020, at 10:00 AM Eastern Time.   GlobeNewswire Inc
Nov 11, 2020
07:00AM EST  Additional data on first non-invasive medical device cleared by the FDA for OCDdemonstratedthat 73% responded positivelyto Deep TMS,anddurability of therapeutic effect was shown   GlobeNewswire Inc
Nov 4, 2020
07:00AM EST  BrainsWay to Report Third Quarter 2020 Financial Results and   GlobeNewswire Inc
Nov 2, 2020
08:00AM EST  BrainsWay to Participate in Two Upcoming Investor Conferences   GlobeNewswire Inc
Oct 13, 2020
09:00AM EDT  BrainsWay Ltd. (NASDAQ & TASE: BWAY) (BrainsWay or the Company), a global leader in the advanced noninvasive treatment of brain disorders, today announced its #TheRealOCD campaign in conjunction with Obsessive-Compulsive Disorder (OCD) Awareness Week, which takes place October 11 17, 2020.   GlobeNewswire Inc
Oct 6, 2020
09:00AM EDT  BrainsWay Ltd. (NASDAQ & TASE: BWAY) (BrainsWay or the Company), a global leader in the advanced non-invasive treatment of brain disorders, today announced that 10 of the poster presentations accepted to the annual Clinical TMS Poster session highlight the benefits and potential of Deep TMS in the treatment of mental illnesses and brain disorders.   GlobeNewswire Inc
Sep 8, 2020
07:00AM EDT  BrainsWay Ltd. (NASDAQ & TASE: BWAY) (BrainsWay or the Company), a global leader in the advanced non-invasive treatment of brain disorders, today announced that Christopher von Jako, Ph.D., President and Chief Executive Officer, will present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on Tuesday, September 22 at 1:40 PM ET.   GlobeNewswire Inc
Sep 4, 2020
09:40AM EDT  Brainsway F-3 Filing Shows Registration For $75M Mixed Securities Offering   Benzinga
Sep 2, 2020
07:00AM EDT  BrainsWay Ltd. (NASDAQ & TASE: BWAY) (BrainsWay or the Company), a global leader in the advanced non-invasive treatment of brain disorders, today announced that Christopher von Jako, Ph.D., President and Chief Executive Officer, will present at the H.C. Wainwright 22nd Annual Global Investment Conference and the Cantor Fitzgerald Virtual Global Healthcare Conference.   GlobeNewswire Inc
Aug 24, 2020
07:04AM EDT  BrainsWay Gets 510(k) Clearance From FDA For Smoking Addiction In Adults   RTTNews
07:02AM EDT  BrainsWay Receives 501(k) Clearance from the FDA for the Company's Deep Transcranial Magnetic Stimulation System as an Aid in Short-Term Smoking Cessation   Benzinga
07:00AM EDT  Company Intends to Execute a Controlled U.S. Market Release in Early 2021   GlobeNewswire Inc
Aug 13, 2020
07:21AM EDT  Raymond James Maintains Outperform on Brainsway, Lowers Price Target to $9   Benzinga
Aug 12, 2020
07:24AM EDT  Brainsway: Q2 Earnings Insights   Benzinga
07:19AM EDT  BrainsWay Q2 EPS $(0.18) Up From $(0.29) YoY   Benzinga
07:00AM EDT  BrainsWay Ltd. (NASDAQ & TASE: BWAY) (BrainsWay or the Company), a global leader in the advanced non-invasive treatment of brain disorders, today reported financial results for the quarter ended June 30, 2020, and provided an operational update.   GlobeNewswire Inc
04:21AM EDT  Earnings Scheduled For August 12, 2020   Benzinga
Jul 29, 2020
07:00AM EDT  BrainsWay to Report Second Quarter 2020 Financial Results and   GlobeNewswire Inc
Jul 21, 2020
09:00AM EDT  BrainsWay Ltd. (NASDAQ & TASE: BWAY) (BrainsWay or the Company), a global leader in the advanced noninvasive treatment of brain disorders, today announced the Company will participate in the upcoming mental health conferences:   GlobeNewswire Inc
09:00AM EDT  University TMS, a mental health facility specializing in advanced treatments for neurological and psychiatric disorders, is now offering BrainsWays Deep Transcranial Magnetic Stimulation (Deep TMS) for major depressive disorder (MDD) and obsessive-compulsive disorder (OCD).   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC